Cargando…

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls

BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernsmeier, Christine, Weisskopf, Diego M., Pflueger, Marlon O., Mosimann, Jan, Campana, Benedetta, Terracciano, Luigi, Beglinger, Christoph, Heim, Markus H., Cajochen, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648512/
https://www.ncbi.nlm.nih.gov/pubmed/26576055
http://dx.doi.org/10.1371/journal.pone.0143293
_version_ 1782401247549063168
author Bernsmeier, Christine
Weisskopf, Diego M.
Pflueger, Marlon O.
Mosimann, Jan
Campana, Benedetta
Terracciano, Luigi
Beglinger, Christoph
Heim, Markus H.
Cajochen, Christian
author_facet Bernsmeier, Christine
Weisskopf, Diego M.
Pflueger, Marlon O.
Mosimann, Jan
Campana, Benedetta
Terracciano, Luigi
Beglinger, Christoph
Heim, Markus H.
Cajochen, Christian
author_sort Bernsmeier, Christine
collection PubMed
description BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake cycle in the pathogenesis of human non-alcoholic fatty liver disease (NAFLD) is indeterminate. We sought to detail sleep characteristics, daytime sleepiness and meal times in relation to disease severity in patients with NAFLD. METHODS: Basic Sleep duration and latency, daytime sleepiness (Epworth sleepiness scale), Pittsburgh sleep quality index, positive and negative affect scale, Munich Chronotype Questionnaire and an eating habit questionnaire were assessed in 46 patients with biopsy-proven NAFLD and 22 healthy controls, and correlated with biochemical and histological parameters. RESULTS: In NAFLD compared to healthy controls, time to fall asleep was vastly prolonged (26.9 vs. 9.8 min., p = 0.0176) and sleep duration was shortened (6.3 vs. 7.2 hours, p = 0.0149). Sleep quality was poor (Pittsburgh sleep quality index 8.2 vs. 4.7, p = 0.0074) and correlated with changes in affect. Meal frequency was shifted towards night-times (p = 0.001). In NAFLD but not controls, daytime sleepiness significantly correlated with liver enzymes (ALAT [r = 0.44, p = 0.0029], ASAT [r = 0.46, p = 0.0017]) and insulin resistance (HOMA-IR [r = 0.5, p = 0.0009]) independent of cirrhosis. In patients with fibrosis, daytime sleepiness correlated with the degree of fibrosis (r = 0.364, p = 0.019). CONCLUSIONS: In NAFLD sleep duration was shortened, sleep onset was delayed and sleep quality poor. Food-intake was shifted towards the night. Daytime sleepiness was positively linked to biochemical and histologic surrogates of disease severity. The data may indicate a role for sleep-wake cycle regulation and timing of food-intake in the pathogenesis of human NAFLD as suggested from murine models.
format Online
Article
Text
id pubmed-4648512
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46485122015-11-25 Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls Bernsmeier, Christine Weisskopf, Diego M. Pflueger, Marlon O. Mosimann, Jan Campana, Benedetta Terracciano, Luigi Beglinger, Christoph Heim, Markus H. Cajochen, Christian PLoS One Research Article BACKGROUND & AIMS: Sleep disturbance is associated with the development of obesity, diabetes and hepatic steatosis in murine models. Hepatic triglyceride accumulation oscillates in a circadian rhythm regulated by clock genes, light-dark cycle and feeding time in mice. The role of the sleep-wake cycle in the pathogenesis of human non-alcoholic fatty liver disease (NAFLD) is indeterminate. We sought to detail sleep characteristics, daytime sleepiness and meal times in relation to disease severity in patients with NAFLD. METHODS: Basic Sleep duration and latency, daytime sleepiness (Epworth sleepiness scale), Pittsburgh sleep quality index, positive and negative affect scale, Munich Chronotype Questionnaire and an eating habit questionnaire were assessed in 46 patients with biopsy-proven NAFLD and 22 healthy controls, and correlated with biochemical and histological parameters. RESULTS: In NAFLD compared to healthy controls, time to fall asleep was vastly prolonged (26.9 vs. 9.8 min., p = 0.0176) and sleep duration was shortened (6.3 vs. 7.2 hours, p = 0.0149). Sleep quality was poor (Pittsburgh sleep quality index 8.2 vs. 4.7, p = 0.0074) and correlated with changes in affect. Meal frequency was shifted towards night-times (p = 0.001). In NAFLD but not controls, daytime sleepiness significantly correlated with liver enzymes (ALAT [r = 0.44, p = 0.0029], ASAT [r = 0.46, p = 0.0017]) and insulin resistance (HOMA-IR [r = 0.5, p = 0.0009]) independent of cirrhosis. In patients with fibrosis, daytime sleepiness correlated with the degree of fibrosis (r = 0.364, p = 0.019). CONCLUSIONS: In NAFLD sleep duration was shortened, sleep onset was delayed and sleep quality poor. Food-intake was shifted towards the night. Daytime sleepiness was positively linked to biochemical and histologic surrogates of disease severity. The data may indicate a role for sleep-wake cycle regulation and timing of food-intake in the pathogenesis of human NAFLD as suggested from murine models. Public Library of Science 2015-11-17 /pmc/articles/PMC4648512/ /pubmed/26576055 http://dx.doi.org/10.1371/journal.pone.0143293 Text en © 2015 Bernsmeier et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bernsmeier, Christine
Weisskopf, Diego M.
Pflueger, Marlon O.
Mosimann, Jan
Campana, Benedetta
Terracciano, Luigi
Beglinger, Christoph
Heim, Markus H.
Cajochen, Christian
Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title_full Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title_fullStr Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title_full_unstemmed Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title_short Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
title_sort sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy controls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648512/
https://www.ncbi.nlm.nih.gov/pubmed/26576055
http://dx.doi.org/10.1371/journal.pone.0143293
work_keys_str_mv AT bernsmeierchristine sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT weisskopfdiegom sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT pfluegermarlono sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT mosimannjan sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT campanabenedetta sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT terraccianoluigi sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT beglingerchristoph sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT heimmarkush sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols
AT cajochenchristian sleepdisruptionanddaytimesleepinesscorrelatingwithdiseaseseverityandinsulinresistanceinnonalcoholicfattyliverdiseaseacomparisonwithhealthycontrols